Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-18-002426

← back to feed
Filed
Dec 31, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Dec 27, 2018 100M sh
Current Liabilities Q3 2018 · Sep 30, 2018 $183.17K
Current Liabilities Q3 2018 · Dec 31, 2017 $105.43K
Total Liabilities Q3 2018 · Sep 30, 2018 $183.17K
Total Liabilities Q3 2018 · Dec 31, 2017 $105.43K
Current Assets Q3 2018 · Sep 30, 2018 $7.8K
Current Assets Q3 2018 · Dec 31, 2017 $1.19K
Total Assets Q3 2018 · Sep 30, 2018 $7.8K
Total Assets Q3 2018 · Dec 31, 2017 $1.19K
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$299.74K
Cash And Equivalents Q3 2018 · Sep 30, 2017 $1.19K
Cash And Equivalents Q3 2018 · Dec 31, 2016 $100.93K
Sga Expense Q3 2018 · Sep 30, 2017 $21.36K
Sga Expense Q3 2018 · Sep 30, 2017 $159.87K
Net Income Q3 2018 · Sep 30, 2017 −$21.36K
Net Income Q3 2018 · Sep 30, 2017 −$159.86K
Operating Income Q3 2018 · Sep 30, 2017 −$21.36K
Operating Income Q3 2018 · Sep 30, 2017 −$159.87K